PERFORMANCE ANALYSIS OF PHARMACEUTICAL COMPANIES DURING THE PANDEMIC CRISIS
Analysing the financial performance of companies involves examining various aspects of a company’s financial activity, including profitability, liquidity, solvency, rate of return, cash flow and debt ratio. Beside the detailed information on the financial situation of a company, the financial perf...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editura Univeristatii "Stefan cel Mare" din Suceava
2023-06-01
|
| Series: | USV Annals of Economics and Public Administration |
| Subjects: | |
| Online Access: | http://annals.feaa.usv.ro/index.php/annals/article/view/1443/1140 |
| Summary: | Analysing the financial performance of companies involves examining various aspects of a company’s
financial activity, including profitability, liquidity, solvency, rate of return, cash flow and debt ratio. Beside the detailed
information on the financial situation of a company, the financial performance analysis can help assess a company’s
potential, including its ability to meet its financial goals. The present paper performs examining of annual financial
reports of three companies from pharmaceutical sector from Romania and analysing key financial indicators during
three years: ante-pandemic, pandemic, post-pandemic. The crisis generated by the COVID-19 pandemic has directly
influenced all economic sectors worldwide, in most cases in a negative sense. At the opposite pole, the pharmaceutical
industry had the opportunity to expand and improve its performance, as a result of the constant market need for
medicines and medical devices. The financial performance analysis of the three most important pharmaceutical
companies from Romania provides detailed information on financial situation of these companies. The paper underlines
the importance of the analysis for making investment, management and strategic decisions, but also to identify trends
and risks and assess the companies’ ability to meet their goals, presiding at the same time measures for long-term
business expansion in a post-pandemic environment.
|
|---|---|
| ISSN: | 2285-3332 2344-3847 |